stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Lenz Therapeutics IncLENZ
$3.500.00%0.00

Lenz Therapeutics Inc (LENZ)

Date: 2026-11-04 16:00O: 3.60H: 3.70L: 3.41C: 3.47Vol: 719.8k
Precedente Chiudi:
$3.50
Aprire:
$3.60
Volume 24 ore:
610,941
Volume relativo:
0.39
Capitalizzazione di mercato:
$109.97M
Reddito:
$19.09M
Utile/perdita netta:
-$82.13M
Rapporto P/E:
-
EPS:
-$2.80
Flusso di cassa netto:
-$70.00M
1W Prestazione:
+9.03%
1M Prestazione:
-2.23%
6M Prestazione:
-62.28%
1Y Prestazione:
-87.52%
Intervallo 1D:
$3.46$3.70
Intervallo di 1 settimana:
$2.80$3.73
Portata 52W:
$2.80$32.13

Profilo aziendale di Lenz Therapeutics Inc (LENZ)

Nome
Lenz Therapeutics Inc
Settore
Healthcare
Industria
Biotechnology
Telefono
858-925-7000
Indirizzo
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH, USA
Dipendente
152
X
-
Prossima data di guadagno
null
Ultimi documenti SEC
SEC
Discussioni di LENZ su X
X

 

Cap. di mercato

 

Reddito

 

Reddito netto

 

Flusso di cassa

 

EPS

 

Lenz Therapeutics Inc Azioni (LENZ) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2026-05-12DowngradePiper SandlerOverweight → Neutral
2025-04-14ResumedPiper SandlerOverweight
2025-03-18IniziatoTD CowenBuy
2024-09-27IniziatoRaymond JamesOutperform

Lenz Therapeutics Inc Azioni (LENZ) Dati Finanziari

PeriodoAndamentoFY 2025FY 2024FY 2023FY 2022FY 2021
Data di fine periodo2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue USD (M)19.09----
Cost of revenue USD (M)0.42----
Research and development USD (M)18.6729.8032.1472.7937.93
Operating expenses USD (M)110.2358.61135.19105.6460.44
Operating income USD (M)-91.14-58.61-135.19-105.64-60.44
Income before tax USD (M)-81.63-49.77---
Income tax expense USD (M)0.500.00-0.000.00
Net income USD (M)-82.13-49.77-124.65-101.05-70.76
Basic EPS USD/shares-2.85-2.34-2.19-1.84-
Diluted EPS USD/shares-2.85-2.34-2.19-1.84-
Basic weighted shares shares (M)28.8121.2857.0254.87-
Diluted weighted shares shares (M)28.8121.2857.0254.87-
Selling, general and administrative USD (M)91.1428.81---

Lenz Therapeutics Inc Azioni (LENZ) insider trading

  • 10% Owner
    Transazione
    Sale
    Costo
    $3.36
    #Azioni
    2,718,684
    Valore ($)
    9,134,778
    #Azioni Totale
    57,559
  • Chief Financial Officer
    Transazione
    Buy
    Costo
    $8.57
    #Azioni
    7,500
    Valore ($)
    64,275
    #Azioni Totale
    12,886
  • President, CEO and Secretary
    Transazione
    Buy
    Costo
    $8.95
    #Azioni
    28,089
    Valore ($)
    251,411
    #Azioni Totale
    77,289
  • Director
    Transazione
    Buy
    Costo
    $8.92
    #Azioni
    5,592
    Valore ($)
    49,890
    #Azioni Totale
    5,592
  • Olsson ShawnNov 17 '25
    Chief Commercial Officer
    Transazione
    Sale
    Costo
    $26.10
    #Azioni
    10,000
    Valore ($)
    261,022
    #Azioni Totale
    4,733
  • SHAWN OLSSONNov 17 '25
    Officer
    Transazione
    Proposed Sale
    Costo
    $25.60
    #Azioni
    40,000
    Valore ($)
    1,024,000
    #Azioni Totale
    0
  • Olsson ShawnNov 17 '25
    Chief Commercial Officer
    Transazione
    Option Exercise
    Costo
    $2.08
    #Azioni
    10,000
    Valore ($)
    20,800
    #Azioni Totale
    14,733
  • Director
    Transazione
    Buy
    Costo
    $22.79
    #Azioni
    10,500
    Valore ($)
    239,278
    #Azioni Totale
    10,500
  • Chief Financial Officer
    Transazione
    Buy
    Costo
    $22.76
    #Azioni
    2,198
    Valore ($)
    50,017
    #Azioni Totale
    5,386
  • 10% Owner
    Transazione
    Sale
    Costo
    $46.01
    #Azioni
    132,944
    Valore ($)
    6,117,323
    #Azioni Totale
    1,050,599
Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
RA CAPITAL MANAGEMENT, L.P.10% OwnerOct 29 '26Sale$3.362,718,6849,134,77857,559
Chevallard Daniel R.Chief Financial OfficerMar 27 '26Buy$8.577,50064,27512,886
Schimmelpennink Evert B.President, CEO and SecretaryMar 27 '26Buy$8.9528,089251,41177,289
George Jeffrey P.DirectorMar 27 '26Buy$8.925,59249,8905,592
Olsson ShawnChief Commercial OfficerNov 17 '25Sale$26.1010,000261,0224,733
SHAWN OLSSONOfficerNov 17 '25Proposed Sale$25.6040,0001,024,0000
Olsson ShawnChief Commercial OfficerNov 17 '25Option Exercise$2.0810,00020,80014,733
MCCOLLUM JAMES WDirectorNov 07 '25Buy$22.7910,500239,27810,500
Chevallard Daniel R.Chief Financial OfficerNov 07 '25Buy$22.762,19850,0175,386
Versant Venture Capital VI, L.10% OwnerSep 30 '25Sale$46.01132,9446,117,3231,050,599

Lenz Therapeutics Inc Borsa (LENZ) Ultime notizie

Nov 03, 2026
Nov 03, 2026
Nov 02, 2026
Nov 02, 2026
Nov 02, 2026
Nov 02, 2026
Nov 02, 2026
Nov 02, 2026
Nov 02, 2026
Nov 02, 2026
Oct 29, 2026
Oct 29, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 28, 2026
Oct 23, 2026
Oct 23, 2026
Oct 21, 2026
Oct 21, 2026
Oct 13, 2026
Oct 13, 2026
Oct 06, 2026
Oct 06, 2026
Sep 11, 2026
Sep 11, 2026
Sep 09, 2026
Sep 09, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 08, 2026
Sep 07, 2026
Sep 07, 2026
Sep 04, 2026
Sep 04, 2026
Sep 04, 2026
Sep 04, 2026
Sep 04, 2026
Sep 04, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 03, 2026
Sep 01, 2026
Sep 01, 2026
Sep 01, 2026
Sep 01, 2026
Aug 31, 2026
Aug 31, 2026
Aug 28, 2026
Aug 28, 2026
Aug 27, 2026
Aug 27, 2026
Aug 27, 2026
Aug 27, 2026
Aug 21, 2026
Aug 21, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 19, 2026
Aug 16, 2026
Aug 16, 2026
Aug 15, 2026
Aug 15, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 14, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 13, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026
Aug 12, 2026

Simile a LENZ